Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by gamakichion May 07, 2019 10:44am

122 Views

Post# 29719392

RE:RE:RE:RE:Top Holdings

added postions, Nice SPCEO

Stewardship Partners Investment Counsel, Inc.	9.74	6,422	246	34	1
LAFOND JOCELYN	0.03	18	17	0	0
TALON JEAN DENIS	0.21	138	15	1	0
BlackRock Fund Advisors	0.04	27	12	0	0
POMMIER PAUL	0.59	390	10	2	0
Vanguard Investments Australia Ltd.	0.02	14	7	0	0
The Vanguard Group, Inc.	0.04	25	7	0	0
KLP Kapitalforvaltning AS	0.02	12	6	0	0
SSgA Funds Management, Inc.	0.09	60	5	0	0
Credit Suisse AG	0.04	26	3	0	0
DUBUC PHILIPPE	0.04	25	3	0	0
Seelaus Asset Management LLC	0.02	15	2	0	0
Marathon Asset Management LLP	0.01	5	1	0	0
State Street Global Advisors Ltd.	0.02	15	1	0	0
Mackenzie Financial Corp.	0.00	1	0	0	0
BlackRock Asset Management Canada Ltd.	0.12	77	0	0	0